Market Cap
¥563.73 Billion
JPY as of July 1, 2025
US$3.93 Billion
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Roche
|
$260.54 B |
Novartis
|
$243.50 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Novo Nordisk
|
$309.91 B |
UnitedHealth Group
|
$279.90 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Japan
languages
Healthcare
languages
Drug Manufacturers—General
Japan Healthcare
Japan Drug Manufacturers—General
Santen Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: JPX: 4536
Stock: FSX: SZD
Stock: OTC: SNPHF
Stock: OTC: SNPHY
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.